Efficacy and safety of telbivudine versus tenofovir treatment based on the Roadmap concept: Results from a randomized, controlled trial in HBeAg-negative chronic hepatitis B patients

Krastev, ZaharyKotzev, Iskren A.Celen, Mustafa K.Mc Neeley, DavidHamed, Kamal A.2024-04-242024-04-2420140270-91391527-3350https://hdl.handle.net/11468/2290065th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- NOV 07-11, 2014 -- Boston, MA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Efficacy and safety of telbivudine versus tenofovir treatment based on the Roadmap concept: Results from a randomized, controlled trial in HBeAg-negative chronic hepatitis B patientsEfficacy and safety of telbivudine versus tenofovir treatment based on the Roadmap concept: Results from a randomized, controlled trial in HBeAg-negative chronic hepatitis B patientsConference Object601104A1104AWOS:000344483804440Q1